7-(chloromethyl)-2-(methylthio)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one, 95.0%, 10g

[S(R)]-N-[(R)-[2-(Dicyclohexylphosphino)phenyl]-2-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 100mg

(R)-2-Fluoropropanoic acid, 98%, 1g

4-Morpholin-4-yl-2-nitrobenzoic acid, 95.0%, 25g

(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine, 97.0%, 1g

Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate, 95.0%, 5g

(11bR)-N,N-Diisopropyl-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 97.0%, 100mg

5-Isopropylisoxazol-4-amine hydrochloride, 98%, 1g

5-(Pyrrolidin-1-yl)pent-3-yn-1-ol, 95.0%, 5g

5-(tert-Butyl) 3-ethyl 6,7-dihydropyrazolo[1,5-a]pyrazine-3,5(4H)-dicarboxylate, 97%, 250mg

2-BROMO-N-(6-METHYL-2,4-BIS(METHYLTHIO)PYRIDIN-3-YL)ACETAMIDE, 90.0%, 100mg

Polydimethylsiloxane, trimethylsiloxy terminated 1,000cSt, 100g

(4-Bromo-naphthalen-1-yloxy)-acetic acid Methyl ester, 95%, 500mg